Study identifies mechanism by which antidepressant fluoxetine increases cAMP signaling in brain cells
Researchers using cell culture models found that the antidepressant fluoxetine increases cyclic adenosine monophosphate (cAMP) levels in astrocytes through a pathway involving serotonin and adenosine receptors, requiring communication between astrocytes and microglia. While SSRIs are widely used and effective for many patients, their full mechanisms of action remain incompletely understood. This finding may help explain how SSRIs work at the cellular level, though further research is needed to confirm relevance in living organisms.
A preprint study published on bioRxiv describes experiments in which researchers exposed primary rat astrocytes to fluoxetine, an SSRI antidepressant, and measured changes in intracellular cAMP using specialized fluorescent sensors. The team found that fluoxetine increased cAMP levels by approximately 28% through a multi-step process: the drug activates serotonin 2B receptors on astrocytes, triggering ATP release; microglia then convert this extracellular ATP to adenosine, which activates adenosine 2B receptors on astrocytes, ultimately raising cAMP. The researchers demonstrated this mechanism by showing that blocking either serotonin or adenosine receptors prevented the cAMP increase, and that depleting microglia from the cultures diminished the effect. The findings suggest that glial cell crosstalk—communication between astrocytes and microglia—is essential for this particular antidepressant effect, adding to the growing understanding that SSRI therapeutic action involves more than simple serotonin reuptake inhibition.
What's missing
This study was conducted in primary rat astrocyte cultures in vitro and has not yet been peer-reviewed or published in a journal. The relevance of these findings to antidepressant effects in living animals or humans remains to be established through further research. The study does not address whether this cAMP pathway is necessary for the clinical antidepressant effects of fluoxetine or whether it occurs in vivo.
What different sources said
- bioRxivCenter
Antidepressant fluoxetine engages astrocytic cAMP via purinergic signalling
Related
Gut Bacteria Enzyme Found to Break Down Heat-Processed Food Compounds, Producing Novel Biogenic Amines
Researchers have discovered that an enzyme in common gut bacteria can degrade N-epsilon-carboxymethyllysine (CML), a compound formed during thermal food processing, producing previously unknown biogenic amines. The enzyme, ornithine decarboxylase SpeC from enterobacteria, acts on CML and related modified lysine derivatives through a low-level 'underground' catalytic activity. This finding suggests a previously unrecognized communication axis between thermally processed dietary compounds and gut microbial physiology, with potential implications for host health.
Full-Length Gene Sequencing Reveals Two Distinct Bacterial Communities in Black-Legged Ticks Expanding Into Canada
Researchers used Oxford Nanopore full-length 16S rRNA gene sequencing to characterize the microbiome of Ixodes scapularis black-legged ticks collected in Nova Scotia, Canada, distinguishing between tick-adapted bacteria and environmentally acquired bacteria. The study comes as I. scapularis — the primary vector of Lyme disease — is rapidly expanding northward into Canada due to climate change. The findings suggest that environmentally derived bacteria in tick microbiomes are not mere contamination, which has implications for how tick microbiome data is collected and interpreted across surveillance studies.
Study Identifies Metabolic Link Between Cell Envelope Stress and Biofilm Formation in Bacteria
Researchers have discovered that the metabolite acetyl-CoA directly inhibits enzymes that degrade the bacterial signaling molecule c-di-GMP, connecting cell envelope biosynthesis stress to biofilm formation in Pseudomonas aeruginosa. The study found that sub-inhibitory concentrations of antibiotics targeting early peptidoglycan biosynthesis — but not other antibiotic classes — elevate c-di-GMP levels by reducing phosphodiesterase activity, with acetyl-CoA competing for the enzyme active site. Because the relevant enzyme domain is broadly conserved across bacterial species, this checkpoint mechanism may be widespread and could have implications for understanding antibiotic-induced biofilm responses.